Attached files
| file | filename |
|---|---|
| EX-23.2 - EX-23.2 - Sienna Biopharmaceuticals, Inc. | d391086dex232.htm |
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - Sienna Biopharmaceuticals, Inc. | d391086ds1a.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 15, 2017, except for the retroactive effect of the 1-for-5.87 reverse stock split as described in Note 1, as to which the date is July 24, 2017, in Amendment No. 2 to the Registration Statement (Form S-1) and related Prospectus of Sienna Biopharmaceuticals, Inc. dated July 24, 2017.
/s/ Ernst & Young LLP
Los Angeles, California
July 24, 2017